Welcome to the Research Navigator – a tool developed by Imperial College Health Partners to help healthcare industries navigate their way around the research sector in North West London, and discover what support is available to help them further test and refine their products before introducing them to the NHS.
Search by tag
The tags contain the full list of research services provided across North West Londoncancel
What do you need help with?
Use the map to see which organisations specialise in designing and delivering research, supporting and funding applications and introducing products/services to the NHS
The Research Design Service (RDS) is a key component of the strategy to make the NHS research intensive and is funded by the National Institute for Health Research (NIHR). The RDS provides free design and methodological support to health researchers who are developing research funding applications. RDS supports research teams to develop and submit high quality applied health and social care grant applications to NIHR and other open, national, peer-reviewed funding programmes. The focus of the service is to improve the quality of research proposals, so that they are more likely to attract funding. The service is delivered across England by region.
RDS London is a collaborative project, led by Kingâ€™s College London, in partnership with Imperial College London, Queen Mary University of London and University College London.
RDS London can advise on all aspects of designing a research study and can support anyone from first-time funding applicants to experienced researchers. Additionally, the service can help identify suitable sources of funding for projects and foster collaborative links with established research groups in the capital.
The NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) was established in April 2008.
We are a team of managers, academics, clinicians, researchers and support staff managed by the NETSCC Board. We manage the identifying, prioritising, funding, delivery, publication and dissemination of high quality research and lead other NIHR initiatives to meet the needs of the public, patients and the NHS.
We have a distinctive approach â€“ adding-value, needs-led and science-added. â€˜Needs-ledâ€™ means that research addresses questions of importance to the NHS and public health. â€˜Science-addedâ€™ ensures that research generates high-quality evidence. This approach is an intensive form of research management, spanning the identification and prioritisation of needs, rigorous peer review, and monitoring of projects. However, the approach greatly increases the value of research findings.
The research our programmes fund has a major impact: it is published in the worldâ€™s leading journals and it makes measurable differences to peopleâ€™s lives and the quality of health services. Our research programmes:
â€¢ Efficacy and Mechanism Evaluation Programme
â€¢ Health Services and Delivery Research Programme
â€¢ Health Technology Assessment Programme
â€¢ Public Health Research Programme
â€¢ Systematic Reviews Programme
Imperial Innovations Group plc (known as Innovations) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research focusing on the â€˜Golden Triangleâ€™, the geographical region broadly bounded by London, Cambridge and Oxford. This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the worldâ€™s top 10 universities, as well as leading research institutions, the cream of the UKâ€™s science and technology businesses and many of its leading investors.
Innovations supports scientists and entrepreneurs in the commercialisation of their ideas, through the licensing of intellectual property, by leading the formation of new companies, by recruiting high- calibre management teams and by providing investment and encouraging co-investment. Innovations provides continuity of funding from start-up to scale-up, with initial investments at the seed and Series A stages. Innovations remains an active investor over the life of its portfolio companies, with the majority of Innovationsâ€™ investment going into businesses in which it is already a shareholder. This significantly reduces the risk of scaling up investment for the portfolio companies.
Innovations has a technology pipeline agreement with Imperial College London that extends until 2020, under the terms of which it has exclusive commercialisation rights and continues to act as the Collegeâ€™s technology transfer office. The Group also acts as the technology transfer office for select NHS Trusts linked to Imperial College London, including Imperial College Healthcare NHS Trust and London North West Healthcare NHS Trust. It runs an incubator in London that is the initial home for many of its technology spin-outs.
The West London Primary Care Research Network Community Interest Company (WeLReN CiC ) is a clinical research network based in North West London. The CiC was formally established in 2012 to co-ordinate, promote and support research activity in both primary and social care, and to develop primary care and public health capacity through medical education and training. The CiC is an active social enterprise with roots and a framework stemming from WeLReN (West London Research Network) which was set up in 1998.
WeLReN CiC is a practice-based research network (PBRN) bringing together GPs, public health professionals, practice nurses, community and allied health practitioners together with academic general practices and researchers in long-term, fruitful and enduring collaborations. Its principle aim is to facilitate the conduct of impactful research studies, including clinical audits, service evaluations and improvement cycles that matter to practitioners affecting a positive difference in the delivery of primary care in the contemporary setting.
WelReN operates via a virtual alliance of over 300 GP practices in West London, with plans to become a pan London outfit offering services to a wide mix of stakeholders. WeLReN CiC is collocated at Imperial College Department of Primary Care and Public Health (Charing Cross Hospital Campus- its academic base) and Northwest London Hospital NHS Trust (Northwick Park Hospital- its clinical base in an NHS setting).
The NIHR Imperial Biomedical Research Centre (BRC) is one of only five National Institute for Health Research (NIHR) BRCs in England. NIHR Imperial BRC is a partnership between Imperial College Healthcare NHS Trust and Imperial College London. The BRC covers 16 research themes reflecting the breadth and quality of research undertaken on Imperial sites. The BRC undertakes translational research, which means taking laboratory research into a clinical setting, or taking the findings from basic research more quickly and efficiently into medical practice and, thus, delivering improved health outcomes for our patients.
BRCs were created by the NIHR to drive progress in innovation and translational biomedical research. BRCs are seen as leaders in scientific translation with a role in driving fundamental biomedical research into clinical research that benefits patients. Imperial NIHR BRC is committed to making our partnership the best place in the world for health research, development and innovation.
To achieve these ambitious goals we work with a large number of partners so our research findings can have an even bigger impact and bring about improvements in the lives of more patients. One vital partnership is with our patients, whose support and involvement we rely on and who are an integral part of the NIHR Imperial BRC. Imperial College Healthcare NHS Trust cares for a population of nearly three million people living in north west London, ranging from Brent to Westminster to Hammersmith, as well patients from all over the UK through specialist services provided at our hospitals.
For all enquiries related to commercial research including site feasibility please contact:
T: 0203 313 4027
For all other enquiries related to research in North West London:
T: 0203 313 4010